玻璃体内注射曲安奈德治疗继发于IRVAN的黄斑水肿(英文)

Treatment of macular oedema secondary to idiopathic retinitis,vasculitis,aneurysms,and neuroretinitis with intravitreal triamcinolone

目的:报告玻璃体内注射曲安奈德对特发性视网膜炎、血管炎、动脉瘤及视神经视网膜炎(IRVAN)所致的黄斑水肿的治疗效果。方法:病例报告。结果:患者诊断为特发性视网膜炎、血管炎、动脉瘤及视神经视网膜炎导致的伴有视力丧失的继发性黄斑水肿。玻璃体内注射曲安奈德后黄斑水肿减轻,视力显著改善。结论:以前的报告建议采取全视网膜光凝,玻璃体切除术及全身和眼部类固醇治疗。对于继发于IRVAN的黄斑水肿和血管炎,玻璃体内注射曲安奈德是一种安全有效的治疗方法。

AIM. To report the treatment of macular oedema secondary to idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis （IRVAN） with intravitreal triamcinolone. METHODS： Case report. RESULTS： A patient diagnosed with IRVAN with visual loss secondary to macular oedema. The macular oedema and her visual acuity was improved dramatically with the administration of intravitreal triamcinolone. CONCLUSION： Previous reports recommend treatment of IRVAN with panretinal photocoagulation, vitrectomy, systemic and periocular steroids. Our case shows that intravitreal triamcinolone appears to be a safe and effective treatment for macular oedema and vasculitis secondary to IRVAN.